Emerging therapies for treatment of multiple sclerosis

John R Corboy, Augusto A MiravalleRocky Mountain Multiple Sclerosis Center, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado, USAAbstract: In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Som...

Full description

Saved in:
Bibliographic Details
Main Authors: John R Corboy, Augusto A Miravalle
Format: article
Language:EN
Published: Dove Medical Press 2010
Subjects:
Online Access:https://doaj.org/article/8e9a9038c8bc4f2da5dd14a4a4fedb5b
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:doaj.org-article:8e9a9038c8bc4f2da5dd14a4a4fedb5b
record_format dspace
spelling oai:doaj.org-article:8e9a9038c8bc4f2da5dd14a4a4fedb5b2021-12-02T02:11:56ZEmerging therapies for treatment of multiple sclerosis1178-7031https://doaj.org/article/8e9a9038c8bc4f2da5dd14a4a4fedb5b2010-07-01T00:00:00Zhttp://www.dovepress.com/emerging-therapies-for-treatment-of-multiple-sclerosis-a4898https://doaj.org/toc/1178-7031John R Corboy, Augusto A MiravalleRocky Mountain Multiple Sclerosis Center, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado, USAAbstract: In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Some of these therapies are showing a high level of efficacy, with an acceptable adverse effect profile. Because present therapies have significant limitations in slowing disease progression, require injections, are sometimes associated with significant side effects of immunosuppression, and do little to reverse disability, identifying more effective treatments is an important goal for clinical research in multiple sclerosis. However, in order to improve our current approach to disease-modifying therapies, it is imperative to promote the development of individualized therapy strategies.Keywords: multiple sclerosis, lymphocyte-targeted therapy, immune sequestration, non-specific immune modulation John R CorboyAugusto A MiravalleDove Medical PressarticlePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol 2010, Iss default, Pp 53-59 (2010)
institution DOAJ
collection DOAJ
language EN
topic Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
John R Corboy
Augusto A Miravalle
Emerging therapies for treatment of multiple sclerosis
description John R Corboy, Augusto A MiravalleRocky Mountain Multiple Sclerosis Center, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado, USAAbstract: In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Some of these therapies are showing a high level of efficacy, with an acceptable adverse effect profile. Because present therapies have significant limitations in slowing disease progression, require injections, are sometimes associated with significant side effects of immunosuppression, and do little to reverse disability, identifying more effective treatments is an important goal for clinical research in multiple sclerosis. However, in order to improve our current approach to disease-modifying therapies, it is imperative to promote the development of individualized therapy strategies.Keywords: multiple sclerosis, lymphocyte-targeted therapy, immune sequestration, non-specific immune modulation
format article
author John R Corboy
Augusto A Miravalle
author_facet John R Corboy
Augusto A Miravalle
author_sort John R Corboy
title Emerging therapies for treatment of multiple sclerosis
title_short Emerging therapies for treatment of multiple sclerosis
title_full Emerging therapies for treatment of multiple sclerosis
title_fullStr Emerging therapies for treatment of multiple sclerosis
title_full_unstemmed Emerging therapies for treatment of multiple sclerosis
title_sort emerging therapies for treatment of multiple sclerosis
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/8e9a9038c8bc4f2da5dd14a4a4fedb5b
work_keys_str_mv AT johnrcorboy emergingtherapiesfortreatmentofmultiplesclerosis
AT augustoamiravalle emergingtherapiesfortreatmentofmultiplesclerosis
_version_ 1718402609001267200